Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 12010 desmopressin-acetÁt - perorální lyofilizát - 240mcg - desmopressin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 12010 desmopressin-acetÁt - perorální lyofilizát - 120mcg - desmopressin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 12010 desmopressin-acetÁt - perorální lyofilizát - 60mcg - desmopressin

Slovenia - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ferring gmbh - dezmopresin - peroralni liofilizat - dezmopresin 120 µg / 1 liofilizat - dezmopresin

Slovenia - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ferring gmbh - dezmopresin - peroralni liofilizat - dezmopresin 60 µg / 1 liofilizat - dezmopresin

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ferring-léčiva, a.s., Česká republika - dezmopresín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ferring-léčiva, a.s., Česká republika - dezmopresín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ferring-léčiva, a.s., Česká republika - dezmopresín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.2 mg (equivalent: desmopressin, qty 178 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; potato starch - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg/ml (equivalent: desmopressin, qty 0.089 mg/ml) - spray, solution - excipient ingredients: dibasic sodium phosphate dihydrate; citric acid monohydrate; sodium chloride; purified water; benzalkonium chloride - diabetes insipidus:the treatment of adh-sensitive cranial diabetes insipidus, including treatment of post-hypophysectomy polydipsia and polyuria.,nocturnal enuresis: minirin nasal spray is indicated for the symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. minirin nasal spray should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is contraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.,renal concentrating capacity: by intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.